EUVIMEDEUVIMED entdecken
Crossref

Tri-Modal Anticancer Therapy via Mo 2 C-MXene-Based Hybrid Nanostructures: A Synergistic Strategy Against Triple-Negative Breast Cancer

Ayça Tunçel, Derya Ozel, Gül Kaya, Buse Sert, Osman Yilmaz, Safiye Aktas, Hatice Efsun Kolatan, Özde Gökbayrak, Cumhur Gökhan Ünlü, Kasim Ocakoglu iD, Fatma Yurt iD

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.5c16111 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Ayça Tunçel und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Engineering, Department of Engineering Fundamental Sciences, Tarsus University, Tarsus 33400, Türkiye. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Paclitaxel, Nanostructures, Molybdenum. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: T??rkiye Bilimsel ve Teknolojik Arastirma Kurumu.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsPaclitaxelNanostructuresMolybdenumAntineoplastic AgentsHumansAnimalsFemaleMiceCell Line, TumorPhotochemotherapyMice, Inbred BALB CCell SurvivalApoptosisReactive Oxygen SpeciesDrug LiberationDrug CarriersNitritesTransition Elements

Stichwörter der Autor:innen

Mo2C@C@Fuc/Mo2C-MXene@Fuc hybrid nanosystemcombined therapyphotodynamic therapy (PDT)photothermal therapy (PTT)reactive oxygen species (ROS)triple-negative breast cancer (TNBC)

Substanzen

PaclitaxelMolybdenumAntineoplastic AgentsReactive Oxygen SpeciesDrug CarriersMXeneNitritesTransition Elements

Autor:innen und Institutionen

  • Faculty of Engineering, Department of Engineering Fundamental Sciences, Tarsus University, Tarsus 33400, Türkiye.
  • Institute Nuclear Science, Department of Nuclear Applications, Ege University, Bornova, Izmir 35100, Türkiye.
  • Institute of Health Sciences, Department of Laboratory Animals, Dokuz Eylül University, İzmir 35210, Türkiye.
  • Institute of Oncology, Department of Basic Oncology, Dokuz Eylul University, Izmir 35000, Türkiye.
  • Faculty of Technology, Department of Biomedical Engineering, Pamukkale University, Denizli 20070, Türkiye.

ORCID-Profile: Kasim Ocakoglu, Fatma Yurt

Förderung

  • T??rkiye Bilimsel ve Teknolojik Arastirma Kurumu

Zitieren

APA

Tunçel, A., Ozel, D., Kaya, G., Sert, B., Yilmaz, O., Aktas, S., Kolatan, H. E., Gökbayrak, Ö., Ünlü, C. G., Ocakoglu, K., & Yurt, F. (2025). Tri-Modal Anticancer Therapy via Mo 2 C-MXene-Based Hybrid Nanostructures: A Synergistic Strategy Against Triple-Negative Breast Cancer. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c16111

Vancouver

Tunçel A, Ozel D, Kaya G, Sert B, Yilmaz O, Aktas S, et al. Tri-Modal Anticancer Therapy via Mo 2 C-MXene-Based Hybrid Nanostructures: A Synergistic Strategy Against Triple-Negative Breast Cancer. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c16111

BibTeX
@article{Tunel2025,
  author = {Tunçel, Ayça and Ozel, Derya and Kaya, Gül and Sert, Buse and Yilmaz, Osman and Aktas, Safiye and Kolatan, Hatice Efsun and Gökbayrak, Özde and Ünlü, Cumhur Gökhan and Ocakoglu, Kasim and Yurt, Fatma},
  title = {Tri-Modal Anticancer Therapy via Mo 2 C-MXene-Based Hybrid Nanostructures: A Synergistic Strategy Against Triple-Negative Breast Cancer},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.5c16111}
}
Kostenlos starten →